Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers

Bistra Galunska,Yoto Yotov,Miglena Nikolova,Atanas Angelov,Galunska,Yotov,Nikolova,Angelov

DOI: https://doi.org/10.3390/ijms25063517

IF: 5.6

2024-03-21

International Journal of Molecular Sciences

Abstract:One mechanism to regulate pathological vascular calcification (VC) is its active inhibition. Loss or inactivation of endogenic inhibitors is a major inductor of VC. Such inhibitors are proteins rich in gamma-glutamyl residues (Gla-proteins), whose function strongly depends on vitamin K. The current narrative review is focused on discussing the role of extrahepatic vitamin K-dependent Gla-proteins (osteocalcin, OC; matrix Gla-protein, MGP; Gla-rich protein, GRP) in cardio-vascular pathology. Gla-proteins possess several functionally active forms whose role in the pathogenesis of VC is still unclear. It is assumed that low circulating non-phosphorylated MGP is an indicator of active calcification and could be a novel biomarker of prevalent VC. High circulating completely inactive MGP is proposed as a novel risk factor for cardio-vascular events, disease progression, mortality, and vitamin K deficiency. The ratio between uncarboxylated (ucOC) and carboxylated (cOC) OC is considered as an indicator of vitamin K status indirectly reflecting arterial calcium. Despite the evidence that OC is an important energy metabolic regulator, its role on global cardio-vascular risk remains unclear. GRP acts as a molecular mediator between inflammation and calcification and may emerge as a novel biomarker playing a key role in these processes. Gla-proteins benefit clinical practice as inhibitors of VC, modifiable by dietary factors.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of vitamin K - dependent extracellular hepatic Gla proteins (such as osteocalcin, matrix Gla protein, Gla - rich protein) in cardiovascular pathology, and their relationship with the degree of arterial calcification, especially how the different circulating forms of these proteins interact with traditional metabolic and etiological risk factors and thus may serve as new biomarkers for cardiovascular disease (CVD). The paper focuses on the role of these Gla proteins in regulating the process of vascular calcification, especially how they are affected by vitamin K levels, and whether the active forms of these proteins can be increased through dietary or therapeutic interventions to improve cardiovascular health.

Specifically, the paper discusses the following aspects:
1. **Pathophysiology of Vascular Calcification**: It introduces the mechanisms of vascular calcification, including the trans - differentiation of vascular smooth muscle cells into osteoblast - like cells, a process that leads to the formation of osteoid matrix in the vascular wall.
2. **Gla Proteins as Regulatory Molecules for Ectopic Calcification**: It describes in detail the biosynthesis, secretion and functional forms of Gla proteins, emphasizing the role of these proteins in inhibiting vascular calcification.
3. **Matrix Gla Protein (MGP)**: It delves into the different functional forms of MGP (such as fully active phosphorylated and carboxylated MGP, partially active non - phosphorylated and carboxylated MGP, etc.), and the relationship between these forms and vascular calcification.
4. **MGP and Risk Factors for Cardiovascular Disease**: It analyzes the correlation between MGP and known risk factors for cardiovascular disease (such as age, sex, smoking, obesity, hypertension and hyperlipidemia).

In conclusion, this paper aims to clarify the potential role of vitamin K - dependent extracellular hepatic Gla proteins in cardiovascular disease by synthesizing existing research, providing new perspectives and strategies for the prevention and treatment of cardiovascular disease.